Brain Cancer Diagnostics Market Forecast to 2028

Brain Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Diagnostic Type (Imaging Test [MRI, CT Scan, PET, and Others], Lumbar Puncture, Biopsy, Molecular Testing, Platform and Services [Sample Slide, Autosampler Unit, Solutions & Platform, and Services], Cerebral Arteriogram, Neurological & Hearing Tests/Neurocognitive Assessments, Electroencephalography (EEG), and Others); Cancer Type (Acoustic Neuroma, Astrocytomas, Craniopharyngiomas, Ganglioneuromas, Glioblastoma Multiforme, Meningiomas, Ependymomas, Oligodendroglioma, Low-Grade Tumors, and Others); End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Diagnostic Centers & Research Institutes, and Others); and Tumor Size (0.2 cm3 to 100 cm3, 101 cm3 to 200 cm3, and Above 200 cm3)

Report Code : TIPRE00024461 | Region : Global | Industry : Medical Device | Published Date : 23/Jun/2022

The global brain cancer diagnostics market is expected to grow from US$ 1,639.10 million in 2022 to US$ 7,378.57 million by 2028; it is expected to grow with a CAGR of 28.5% from 2022 to 2028.

The increase in brain cancer worldwide and the rise in cigarette smokers boost the growth of the global brain cancer diagnostics market.

The term "primary brain tumor" refers to a tumor that begins in the brain. Cancer of the brain and nervous system is the tenth highest cause of mortality in men and women. According to the American Society of Clinical Oncology (ASCO), in 2021, around 24,530 adults (13,840 men and 10,690 women) were diagnosed with primary cancerous tumors of the brain and spinal cord in the US. In a person's lifetime, the chances of having this form of tumor are fewer than 1%. Most primary central nervous system (CNS) malignancies are brain tumors, which account for 85% to 90% of all cases. Brain tumors can be fatal, severely impact the quality of life, and ultimately transform a patient's and their family's lives.

Similarly, Cancer Research UK estimated that around 12,288 new cases of brain, other CNS, and intracranial tumors are diagnosed in the UK each year, which makes it around 34 cases per day (2016–2018). Brain tumors, other central nervous systems, and intracranial tumors are the ninth most common malignancies in the UK, accounting for 3% of all new cancer cases (2016–2018). Also, it is the 7th most common cancer in females in the UK, with around 6,400 new cases during 2016–2018. Similarly, in males, brain, other CNS, and intracranial tumors are the 11th most common cancer, with about 5,800 new cases in the UK during 2016–2018. Incidence rates for brain tumors are highest in people aged 85 to 89 (2016-2018) in the UK.

According to the American Association of Neurological Surgeons, glioblastoma is the most common malignant brain and other CNS tumor, accounting for 47.7% of all cases; the incidence of glioblastoma is 3.21 per 100,000 people. According to Cancer Australia, around 1,879 new cases of brain cancer were diagnosed in Australia in 2020.

Early detection of tumors often provides more treatment options. Advanced imaging technology can pinpoint the location of brain tumors. Intraoperative MRI can also be used to guide tissue biopsy and tumor resection during surgery. Magnetic resonance spectroscopy (MRS) is used to examine the chemical characteristics of tumors. Thus, the increase in the prevalence of brain cancer worldwide highly demands brain cancer diagnostic tools.

The COVID-19 pandemic diverted resources from healthcare services for patients with diseases such as cancer. The brain cancer diagnostics market witnessed some shortfall at the beginning of the COVID-19 crisis owing to factors such as disruption in the supply chain and demand due to the lack of lockdown announced by most countries. Patients with cancer were negatively impacted during the COVID-19 pandemic, as many of these individuals were immunosuppressed and of older age. Additionally, cancer follow-up or imaging appointments were delayed in many clinics worldwide. Postponement of routine screening examinations resulted in delays in new cancer diagnoses. A delay in cancer diagnosis due to the COVID-19 pandemic resulted in an increase in cancer-related mortality. Studies on COVID-19 in patients with cancer were limited but consistently indicate that this population is at risk for more severe COVID-19 illness. Recent studies also suggest that pediatric patients with cancer have a lower risk of severe COVID-19 illness than adults. Thus, the pandemic had a negative impact on the growth of the brain cancer diagnostics market.

Based on diagnostics type, the brain cancer diagnostics market is segmented into imaging test, lumbar puncture, biopsy, molecular testing, platform & services, cerebral arteriogram, neurological & hearing tests/neurocognitive assessments, electroencephalography (EEG), and others. Molecular testing segment further sub-segmented into MRI, CT scan, PET, and others. Platform & services segment is further sub-segmented into sample slide, autosampler unit, solutions and platform, and services. In 2022, the imaging test segment is expected to have the largest market share. Moreover, the platform and services market for this segment is estimated to grow at the fastest CAGR during the forecast period.

Based on cancer type, the brain cancer diagnostics market is segmented into acoustic neuroma, astrocytomas, craniopharyngiomas, ganglioneuromas, glioblastoma multiforme, ganglioneuroma, meningiomas, ependymomas, oligodendroglioma, low-grade tumors, and others. In 2022, the glioblastoma multiforme segment is estimated to hold the largest market share. The same segment is expected to register the highest CAGR from 2022 to 2028.

Based on tumor size, the brain cancer diagnostics market is segmented into 0.2 cm3 to 100 cm3, 101 cm3 to 200 cm3, and above 200 cm3. In 2022, the 0.2 cm3 to 100 cm3 segment is estimated to hold the largest share of the market. The same segment is expected to register the highest CAGR from 2022 to 2028.

Based on end user, the brain cancer diagnostics market is segmented into hospitals, specialty clinics, ambulatory surgical centers, diagnostic centers & research institutes, and others. In 2022, the hospitals segment is expected to account for the largest share of the market. Moreover, the specialty clinics segment is expected to register the highest CAGR from 2022 to 2028.

American Society of Clinical Oncology (ASCO), American Association of Neurological Surgeons, Centers for Disease Control and Prevention (CDC), World Health Organization, National Library of Medicine, The American Cancer Society, Japan Radiology Society, Globocan 2020 are among the primary and secondary sources referred to while preparing the report on the brain cancer diagnostics market.

Glioblastoma Multiforme Segment to Lead Brain Cancer Diagnostics Market During 2021–2028

According to our latest study on “Brain Cancer Diagnostic Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Diagnostic Type, Cancer Type, End User, Tumor Size, and Geography," the market is expected to reach US$ 7,378.57 million in 2028 from US$ 1,639.10 million in 2022; it is estimated to grow at a CAGR of 28.5.% during 2022–2028. The report highlights the key factors driving the brain cancer diagnostic market growth and prominent players with their developments in the brain cancer diagnostic market.

Brain cancers are caused due to extracellular growth of the cells in the brain that causes tumors. The tumor includes primary brain tumors and secondary brain tumors. Primary brain tumors are formed in the brain and do not spread to other body parts, whereas secondary tumors, also known as metastases, are those cancers that began in another part of the body. Brain tumors are categorized into 40 major types that are further classified into two major groups. Benign tumor is slow-growing and have less possibility to spread, and malignant tumor is cancerous and more likely to spread. The growth of the brain cancer diagnostics market is primarily attributed to the rising incidence of brain cancer and an increasing number of cigarette smokers worldwide. However, the high cost of brain tumor diagnosis restricts the market growth.

The global brain cancer diagnostic market, based on cancer type, is segmented into acoustic neuroma, astrocytomas, craniopharyngiomas, ganglioneuromas, glioblastoma multiforme, meningiomas, ependymomas, oligodendroglioma, low-grade tumors, and other brain cancer types. In 2021, the glioblastoma multiforme segment is likely to account the largest share of the market. Moreover, the same segment is expected to witness growth in its demand at the fastest CAGR from 2021 to 2028, owing to the rise in the incidence of glioblastoma multiforme globally. Glioblastoma Multiforme (GBM) is a fast-growing and aggressive brain tumor known as a grade IV astrocytoma. It penetrates surrounding brain tissue but does not usually spread to other organs. GBMs can develop spontaneously in the brain or from a lower-grade astrocytoma. GBM most commonly affects adults in the cerebral hemispheres, particularly the frontal and temporal lobes. GBM is a fatal brain cancer that can kill patients in six months or less if left untreated. It is critical to seek expert neuro-oncological and neurosurgical care as soon as possible, as this can affect overall survival. Sophisticated imaging techniques such as computed tomography (CT scan) and magnetic resonance imaging (MRI) can accurately pinpoint the location of brain tumors. Growing awareness about glioblastoma multiforme is driving the market growth.

THERMO FISHER SCIENTIFIC INC; Siemens Healthineers AG; GE Healthcare; MDxHealth; NantOmics; Biocept, Inc.; Koninklijke Philips N.V.; Canon Medical Systems; Hitachi, Ltd.; Neusoft Medical Systems; KITZ HEIDELBERG; GENPATH; NVIDIA CORPORATION; ONCORA MEDICAL; BIOMIND; SOPHIA AND ONCODNA; Clinspec Diagnostics; Raindance Technologies, Inc; ROCHE DIAGNOSTICS; and Illumina, Inc are among the key players operating in the Brain Cancer Diagnostics market.

Brain Cancer Diagnostics Market, by Cancer type, 2021 (%)

Source: The Insight Partners Analysis

The report segments the Brain Cancer Diagnostics market as follows:

Based on diagnostic type, the brain cancer diagnostics market is segmented into imaging test, lumbar puncture, biopsy, molecular testing, platform and services, cerebral arteriogram, neurological and hearing tests/neurocognitive assessments, electroencephalography (EEG), and others. Furthermore, the imaging test segment is sub-segmented into MRI, CT Scan, PET, and others. Similarly, the platform and services segment is sub-segmented into sample slide, autosampler unit, solutions and platform, and services. Based on cancer type, the market is segmented into acoustic neuroma, astrocytomas, craniopharyngiomas, ganglioneuromas, glioblastoma multiforme, ganglioneuroma, meningiomas, ependymomas, oligodendroglioma, low-grade tumors, and other brain cancer types. Based on tumor size, the market is segmented into 0.2 cm3 to 100 cm3, 101 cm3 to 200 cm3, and above 200 cm3. Based on end user, the market is segmented into hospitals, specialty clinics, ambulatory surgical centers, diagnostic centers & research institutes, and others. By geography, the market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Brain Cancer Diagnostics Market – By Diagnostic Type

1.3.2 Global Brain Cancer Diagnostics Market – By y Cancer Type

1.3.3 Global Brain Cancer Diagnostics Market – By End User

1.3.4 Global Brain Cancer Diagnostics Market – By Tumor Size

1.3.5 Global Brain Cancer Diagnostics Market – By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Brain Cancer Diagnostics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East and Africa PEST Analysis

4.2.5 South and Central America PEST Analysis

4.3 Experts Opinion

5. Brain Cancer Diagnostics Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Brain Cancer Worldwide

5.1.2 Rise in Cigarette Smokers

5.2 Market Restraints

5.2.1 High Cost of Brain Tumor Diagnosis

5.3 Market Opportunities

5.3.1 Increasing R&D for Developing Advance Technology

5.4 Future Trends

5.4.1 Advancement in Brain Tumor Diagnosis

5.5 Impact Analysis

6. Brain Cancer Diagnostics Market– Global Analysis

6.1 Global Brain Cancer Diagnostics Market Revenue Forecast And Analysis

6.1.1 Global Brain Cancer Diagnostics Market Revenue Forecast And Analysis

6.1.2 Global Brain Cancer Diagnostics Market – Market Potential Analysis, By Region

6.2 Market Positioning Analysis Of Key Players In Brain Cancer Diagnostics Market

6.2.1 Company Analysis

6.2.2 Growth Strategy Analysis

6.2.3 Performance Of Key Players

6.2.3.1 Koninklijke Philips N.V.

6.2.3.2 GE Healthcare

7. Global Brain Cancer Diagnostic Market Revenue and Forecasts To 2028– by Diagnostic Type

7.1 Overview

7.2 Global Brain Cancer Diagnostic Market, By Diagnostic Type, 2021 & 2028 (%)

7.3 Imaging Test

7.3.1 Overview

7.3.2 Imaging Test: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)

7.3.2.1 MRI

7.3.2.1.1 Overview

7.3.2.1.2 MRI: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.2 CT Scan

7.3.2.2.1 Overview

7.3.2.2.2 CT Scan: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.3 PET

7.3.2.3.1 Overview

7.3.2.3.2 PET: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.4 Others

7.3.2.4.1 Overview

7.3.2.4.2 Others: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)

7.4 Molecular Testing

7.4.1 Overview

7.4.2 Molecular Testing: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)

7.5 Lumbar Puncture

7.5.1 Overview

7.5.2 Lumbar Puncture: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)

7.6 Electroencephalography (EEG)

7.6.1 Overview

7.6.2 Electroencephalography (EEG): Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)

7.7 Platform and Services

7.7.1 Overview

7.7.2 Platform and Services: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)

7.7.2.1 Sample Slide

7.7.2.1.1 Overview

7.7.2.1.2 Sample Slide: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)

7.7.2.2 Autosampler Unit

7.7.2.2.1 Overview

7.7.2.2.2 Autosampler Unit: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)

7.7.2.3 Solutions and Platform

7.7.2.3.1 Overview

7.7.2.3.2 Solutions and Platform: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)

7.7.2.4 Services

7.7.2.4.1 Overview

7.7.2.4.2 Services: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)

7.8 Cerebral arteriogram

7.8.1 Overview

7.8.2 Cerebral arteriogram: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)

7.9 Neurological and hearing tests/Neurocognitive Assessments

7.9.1 Overview

7.9.2 Neurological and hearing tests/Neurocognitive Assessments: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)

7.10 Others

7.10.1 Overview

7.10.2 Others: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)

8. Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 – Cancer Type

8.1 Overview

8.2 Global Brain Cancer Diagnostic Market Share by Cancer Type - 2021 & 2028 (%)

8.3 Glioblastoma Multiforme

8.3.1 Overview

8.3.2 Glioblastoma Multiforme: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)

8.4 Astrocytomas

8.4.1 Overview

8.4.2 Astrocytomas: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)

8.5 Ependymomas

8.5.1 Overview

8.5.2 Ependymomas: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)

8.6 Meningiomas

8.6.1 Overview

8.6.2 Meningiomas: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)

8.7 Low-Grade Tumors

8.7.1 Overview

8.7.2 Low-Grade Tumors: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)

8.8 Oligodendroglioma

8.8.1 Overview

8.8.2 Oligodendroglioma: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)

8.9 Acoustic Neuroma

8.9.1 Overview

8.9.2 Acoustic Neuroma: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)

8.10 Craniopharyngiomas

8.10.1 Overview

8.10.2 Craniopharyngiomas: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)

8.11 Ganglioneuromas

8.11.1 Overview

8.11.2 Ganglioneuromas: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)

8.12 Others

8.12.1 Overview

8.12.2 Others: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)

9. Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 – Tumor Size

9.1 Overview

9.2 Global Brain Cancer Diagnostic Market Share by Tumor Size - 2021 & 2028 (%)

9.3 0.2 cm3 to 100 cm3

9.3.1 Overview

9.3.2 0.2 cm3 to 100 cm3: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)

9.4 cm3 to 200 cm3

9.4.1 Overview

9.4.2 cm3 to 200 cm3: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)

9.5 Above 200 cm3

9.5.1 Overview

9.5.2 Above 200 cm3: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)

10. Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 – End User

10.1 Overview

10.2 Global Brain Cancer Diagnostic Market Share by End User- 2021 & 2028 (%)

10.3 Hospitals

10.3.1 Overview

10.3.2 Hospitals: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)

10.4 Specialty Clinics

10.4.1 Overview

10.4.2 Specialty Clinics: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)

10.5 Diagnostic Centers and Research Institutes

10.5.1 Overview

10.5.2 Diagnostic Centers and Research Institutes: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)

10.6 Ambulatory Surgical Centers

10.6.1 Overview

10.6.2 Ambulatory Surgical Centers: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)

10.7 Others

10.7.1 Overview

10.7.2 Others: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)

11. Brain Cancer Diagnostics Market Revenue and Forecast to 2028 – by Geography

11.1 North America: Brain Cancer Diagnostics Market

11.1.1 Overview

11.1.2 North America Brain Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

11.1.3 North America Brain Cancer Diagnostics Market, by Diagnostic Type– Revenue and Forecast to 2028 (US$ Million)

11.1.3.1 North America Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (US$ Million)

11.1.3.2 North America Brain Cancer Diagnostics Market, by Platform and Services – Revenue and Forecast to 2028 (US$ Million)

11.1.4 North America Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (US$ Million)

11.1.5 North America Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11.1.6 North America Brain Cancer Diagnostics Market, by Tumor Size– Revenue and Forecast to 2028 (US$ Million)

11.1.7 North America: Brain Cancer Diagnostics Market, by Country, 2022 & 2028 (%)

11.1.7.1 US: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.1 Overview

11.1.7.1.2 US: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.3 US Brain Cancer Diagnostics Market, by Diagnostic Type– Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.3.1 US Brain Cancer Diagnostics Market, by Imaging Test– Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.3.2 US Brain Cancer Diagnostics Market, by Platform and Services– Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.4 US Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.5 US Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.6 US Brain Cancer Diagnostics Market, by Tumor Size – Revenue and Forecast to 2028 (US$ Million)

11.1.7.2 Canada: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.1 Overview

11.1.7.2.2 Canada: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.3 Canada Brain Cancer Diagnostics Market, by Diagnostic Type– Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.3.1 Canada Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.3.2 Canada Brain Cancer Diagnostics Market, by Platform and Services – Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.4 Canada Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.5 Canada Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.6 Canada Brain Cancer Diagnostics Market, by Tumor Size– Revenue and Forecast to 2028 (US$ Million)

11.1.7.3 Mexico: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.1 Overview

11.1.7.3.2 Mexico: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.3 Mexico Brain Cancer Diagnostics Market, by Diagnostic Type– Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.3.1 Mexico Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.3.2 Mexico Brain Cancer Diagnostics Market, by Platform and Services – Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.4 Mexico Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.5 Mexico Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.6 Mexico Brain Cancer Diagnostics Market, by Tumor Size– Revenue and Forecast to 2028 (US$ Million)

11.2 Europe: Brain Cancer Diagnostics Market

11.2.1 Overview

11.2.2 Europe: Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

11.2.3 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

11.2.3.1 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Imaging Test (US$ Mn)

11.2.3.2 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn)

11.2.4 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

11.2.5 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

11.2.6 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Tumor Size (US$ Mn)

11.2.7 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Country (%)

11.2.7.1 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

11.2.7.1.1 Overview

11.2.7.1.2 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

11.2.7.1.3 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

11.2.7.1.3.1 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

11.2.7.1.3.2 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn)

11.2.7.1.4 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

11.2.7.1.5 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

11.2.7.1.6 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Tumor Size (US$ Mn)

11.2.7.2 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

11.2.7.2.1 Overview

11.2.7.2.2 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

11.2.7.2.3 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

11.2.7.2.3.1 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

11.2.7.2.3.2 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn)

11.2.7.2.4 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

LIST OF TABLES.

Table 1. North America Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (US$ Million)

Table 2. North America Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (US$ Million)

Table 3. North America Brain Cancer Diagnostics Market, by Platform and Services – Revenue and Forecast to 2028 (US$ Million)

Table 4. North America Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (US$ Million)

Table 5. North America Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 6. North America Brain Cancer Diagnostics Market, by Tumor Size– Revenue and Forecast to 2028 (US$ Million)

Table 7. US Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (US$ Million)

Table 8. US Brain Cancer Diagnostics Market, by Imaging Test– Revenue and Forecast to 2028 (US$ Million)

Table 9. US Brain Cancer Diagnostics Market, by Platform and Services– Revenue and Forecast to 2028 (US$ Million)

Table 10. US Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (US$ Million)

Table 11. US Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 12. US Brain Cancer Diagnostics Market, by Tumor Size– Revenue and Forecast to 2028 (US$ Million)

Table 13. Canada Brain Cancer Diagnostics Market, by Diagnostic Type-Revenue and Forecast to 2028 (US$ Million)

Table 14. Canada Brain Cancer Diagnostics Market, by Imaging Test -Revenue and Forecast to 2028 (US$ Million)

Table 15. Canada Brain Cancer Diagnostics Market, by Platform and Services -Revenue and Forecast to 2028 (US$ Million)

Table 16. Canada Brain Cancer Diagnostics Market, by Cancer Type -Revenue and Forecast to 2028 (US$ Million)

Table 17. Canada Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 18. Canada Brain Cancer Diagnostics Market, by Tumor Size– Revenue and Forecast to 2028 (US$ Million)

Table 19. Mexico Brain Cancer Diagnostics Market, by Diagnostic Type -Revenue and Forecast to 2028 (US$ Million)

Table 20. Mexico Brain Cancer Diagnostics Market, by Imaging Test -Revenue and Forecast to 2028 (US$ Million)

Table 21. Mexico Brain Cancer Diagnostics Market, by Platform and Services -Revenue and Forecast to 2028 (US$ Million)

Table 22. Mexico Brain Cancer Diagnostics Market, by Cancer Type -Revenue and Forecast to 2028 (US$ Million)

Table 23. Mexico Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 24. Mexico Brain Cancer Diagnostics Market, by Tumor Size– Revenue and Forecast to 2028 (US$ Million)

Table 25. Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 26. Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 27. Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn).

Table 28. Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

Table 29. Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 30. Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Tumor Size (US$ Mn)

Table 31. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type US$ Mn)

Table 32. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test US$ Mn)

Table 33. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services US$ Mn)

Table 34. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type US$ Mn)

Table 35. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User US$ Mn)

Table 36. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Tumor Size US$ Mn)

Table 37. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 38. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 39. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn)

Table 40. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type US$ Mn)

Table 41. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User US$ Mn)

Table 42. Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Tumor Size US$ Mn)

Table 43. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 44. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 45. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn)

Table 46. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

Table 47. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 48. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Tumor Size (US$ Mn)

Table 49. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 50. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 51. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn)

Table 52. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

Table 53. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 54. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Tumor Size (US$ Mn)

Table 55. Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 56. Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 57. Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn)

Table 58. Spain Brain Cancer Diagnostics Market Revenue and Forecast to 2028, by Cancer Type (US$ Million)

Table 59. Spain Brain Cancer Diagnostics Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 60. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)

Table 61. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)

Table 62. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn)

Table 63. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)

Table 64. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)

Table 65. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Tumor Size (US$ Mn)

Table 66. Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million).

Table 67. Asia Pacific: Brain Cancer Diagnostic Market, by Imaging Test – Revenue and Forecast to 2028 (US$ Million)

Table 68. Asia Pacific: Brain Cancer Diagnostic Market, by Platform and Services – Revenue and Forecast to 2028 (US$ Million)

Table 69. Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)

Table 70. Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Tumor Size (US$ Million)

Table 71. Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 72. Japan: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million)

Table 73. Japan: Brain Cancer Diagnostic Market, by Imaging Test– Revenue and Forecast to 2028 (US$ Million)

Table 74. Japan: Brain Cancer Diagnostic Market, by Platform and Services– Revenue and Forecast to 2028 (US$ Million)

Table 75. Japan: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)

Table 76. Japan: Brain Cancer Diagnostic Market, by Tumor Size– Revenue and Forecast to 2028 (US$ Million)

Table 77. Japan: Brain Cancer Diagnostic Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 78. China: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million)

Table 79. China: Brain Cancer Diagnostic Market, by Imaging Test– Revenue and Forecast to 2028 (US$ Million)

Table 80. China: Brain Cancer Diagnostic Market, by Platform and Services– Revenue and Forecast to 2028 (US$ Million)

Table 81. China: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)

Table 82. China: Brain Cancer Diagnostic Market, by Tumor Size– Revenue and Forecast to 2028 (US$ Million)

Table 83. China: Brain Cancer Diagnostic Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 84. India: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million)

Table 85. India: Brain Cancer Diagnostic Market, by Imaging Test– Revenue and Forecast to 2028 (US$ Million)

Table 86. India: Brain Cancer Diagnostic Market, by Platform and Services– Revenue and Forecast to 2028 (US$ Million)

Table 87. India: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)

Table 88. India: Brain Cancer Diagnostic Market, by Tumor Size– Revenue and Forecast to 2028 (US$ Million)

Table 89. India: Brain Cancer Diagnostic Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 90. South Korea: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million)

Table 91. South Korea: Brain Cancer Diagnostic Market, by Imaging Test– Revenue and Forecast to 2028 (US$ Million)

Table 92. South Korea: Brain Cancer Diagnostic Market, by Platform and Services– Revenue and Forecast to 2028 (US$ Million)

Table 93. South Korea: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)

Table 94. South Korea: Brain Cancer Diagnostic Market, by Tumor Size– Revenue and Forecast to 2028 (US$ Million)

Table 95. South Korea: Brain Cancer Diagnostic Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 96. Australia: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million)

Table 97. Australia: Brain Cancer Diagnostic Market, by Imaging Test– Revenue and Forecast to 2028 (US$ Million)

Table 98. Australia: Brain Cancer Diagnostic Market, by Platform and Services– Revenue and Forecast to 2028 (US$ Million)

Table 99. Australia: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)

Table 100. Australia: Brain Cancer Diagnostic Market, by Tumor Size– Revenue and Forecast to 2028 (US$ Million)

Table 101. Australia: Brain Cancer Diagnostic Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 102. Rest of Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million)

Table 103. Rest of Asia Pacific: Brain Cancer Diagnostic Market, by Imaging Test– Revenue and Forecast to 2028 (US$ Million)

Table 104. Rest of Asia Pacific: Brain Cancer Diagnostic Market, by Platform and Services– Revenue and Forecast to 2028 (US$ Million)

Table 105. Rest of Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)

Table 106. Rest of Asia Pacific: Brain Cancer Diagnostic Market, by Tumor Size– Revenue and Forecast to 2028 (US$ Million)

Table 107. Rest of Asia Pacific: Brain Cancer Diagnostic Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 108. Middle East and Africa: Brain Cancer Diagnostics Market, By Diagnostic Type– Revenue and Forecast to 2028 (US$ ‘Million)

Table 109. Middle East and Africa: Brain Cancer Diagnostics Market, By Imaging Test – Revenue and Forecast to 2028 (US$ ‘Million)

Table 110. Middle East and Africa: Brain Cancer Diagnostics Market, By Platform and Services – Revenue and Forecast to 2028 (US$ ‘Million)

Table 111. Middle East and Africa: Brain Cancer Diagnostics Market, By Cancer Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 112. Middle East and Africa: ᮁ Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 113. Middle East and Africa: ᮁ Brain Cancer Diagnostics Market, by Tumor Size– Revenue and Forecast to 2028 (US$ Million)

Table 114. UAE: Brain Cancer Diagnostics Market, By Diagnostic Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 115. UAE: Brain Cancer Diagnostics Market, By Platform and Services – Revenue and Forecast to 2028 (US$ ‘Million)

Table 116. UAE: Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (US$ ‘Million)

Table 117. UAE: ꢒ Brain Cancer Diagnostics Market, By Cancer Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 118. UAE: Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 119. UAE: Brain Cancer Diagnostics Market, by Tumor Size– Revenue and Forecast to 2028 (US$ ‘Million)

Table 120. Saudi Arabia: Brain Cancer Diagnostics Market, By Diagnostic Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 121. Saudi Arabia: Brain Cancer Diagnostics Market, By Imaging Test – Revenue and Forecast to 2028 (US$ ‘Million)

Table 122. Saudi Arabia: Brain Cancer Diagnostics Market, By Platform and Services – Revenue and Forecast to 2028 (US$ ‘Million)

Table 123. Saudi Arabia: ꢒ Brain Cancer Diagnostics Market, By Cancer Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 124. Saudi Arabia: Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 125. Saudi Arabia: Brain Cancer Diagnostics Market, by Tumor Size– Revenue and Forecast to 2028 (US$ ‘Million)

Table 126. South Africa: Brain Cancer Diagnostics Market, By Diagnostic Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 127. South Africa: Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (US$ ‘Million)

Table 128. South Africa: Brain Cancer Diagnostics Market, By Platform and Services – Revenue and Forecast to 2028 (US$ ‘Million)

Table 129. South Africa: Brain Cancer Diagnostics Market, By Cancer Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 130. South Africa: Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 131. South Africa: Brain Cancer Diagnostics Market, by Tumor Size– Revenue and Forecast to 2028 (US$ ‘Million)

Table 132. Rest of Middle East and Africa: Brain Cancer Diagnostics Market, By Diagnostic Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 133. Rest of Middle East and Africa: Brain Cancer Diagnostics Market, By Imaging Test – Revenue and Forecast to 2028 (US$ ‘Million)

Table 134. Rest of Middle East and Africa: Brain Cancer Diagnostics Market, By Platform and Services – Revenue and Forecast to 2028 (US$ ‘Million)

Table 135. Rest of Middle East and Africa: Brain Cancer Diagnostics Market, By Cancer Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 136. Rest of Middle East and Africa: Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (US$ ‘Million)

Table 137. Rest of Middle East and Africa: Brain Cancer Diagnostics Market, by Tumor Size– Revenue and Forecast to 2028 (US$ ‘Million)

Table 138. South and Central America Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (US$ Million)

Table 139. South and Central America Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (US$ Million)

Table 140. South and Central America Brain Cancer Diagnostics Market, by Platform and Services – Revenue and Forecast to 2028 (US$ Million)

Table 141. South and Central America Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (US$ Million)

Table 142. South and Central America Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 143. South and Central America Brain Cancer Diagnostics Market, by Tumor Size – Revenue and Forecast to 2028 (US$ Million)

Table 144. Brazil Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (US$ Million)

Table 145. Brazil Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (US$ Million)

Table 146. Brazil Brain Cancer Diagnostics Market, by Platform and Services – Revenue and Forecast to 2028 (US$ Million)

Table 147. Brazil Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (US$ Million)

Table 148. Brazil Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 149. Brazil Brain Cancer Diagnostics Market, by Tumor Size – Revenue and Forecast to 2028 (US$ Million)

Table 150. Argentina Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (US$ Million)

Table 151. Argentina Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (US$ Million)

Table 152. Argentina Brain Cancer Diagnostics Market, by Platform and Services – Revenue and Forecast to 2028 (US$ Million)

Table 153. Argentina Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (US$ Million)

Table 154. Argentina Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 155. Argentina Brain Cancer Diagnostics Market, by Tumor Size – Revenue and Forecast to 2028 (US$ Million)

Table 156. Rest of South and Central America Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (US$ Million)

Table 157. Rest of South and Central America Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (US$ Million)

Table 158. Rest of South and Central America Brain Cancer Diagnostics Market, by Platform and Services – Revenue and Forecast to 2028 (US$ Million)

Table 159. Rest of South and Central America Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (US$ Million)

Table 160. Rest of South and Central America Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 161. Rest of South and Central America Brain Cancer Diagnostics Market, by Tumor Size – Revenue and Forecast to 2028 (US$ Million)

Table 162. Organic Developments Done By Companies

Table 163. Inorganic Developments Done By Companies

Table 164. Glossary of Terms, Brain Cancer Diagnostics Market

LIST OF FIGURES.

Figure 1. Brain Cancer Diagnostics Market Segmentation

Figure 2. Brain Cancer Diagnostics Market – By Geography

Figure 3. Brain Cancer Diagnostics Market Overview

Figure 4. Amniotic Membranes Held Largest Share by Diagnostics Type of Brain Cancer Diagnostics Market

Figure 5. Asia Pacific to Show Significant Growth During Forecast Period

Figure 6. Brain Cancer Diagnostics Market, by Geography (US$ Million)

Figure 7. Global Brain Cancer Diagnostics Market – Leading Country Markets (US$ Million)

Figure 8. Global Brain Cancer Diagnostics Market, Industry Landscape

Figure 9. North America: PEST Analysis

Figure 10. Europe: PEST Analysis

Figure 11. Asia Pacific: PEST Analysis

Figure 12. Middle East and Africa: PEST Analysis

Figure 13. South and Central America: PEST Analysis

Figure 14. Experts Opinion

Figure 15. Global Brain Cancer Diagnostics Market– Revenue Forecast And Analysis – 2020- 2028

Figure 16. Global Brain Cancer Diagnostics Market– Revenue Forecast And Analysis – 2021 - 2028

Figure 17. Global Brain Cancer Diagnostics Market – Market Potential Analysis, By Region

Figure 18. Market Positioning Analysis Of Key Players In Global Brain Cancer Diagnostics Market

Figure 19. Global Brain Cancer Diagnostics Market – Comparative Company Analysis

Figure 20. Global Brain Cancer Diagnostics Market – Growth Strategy Analysis

Figure 21. Global Brain Cancer Diagnostic Market, by Diagnostic Type, 2021 & 2028 (%)

Figure 22. Imaging Test: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. MRI: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)

Figure 24. CT Scan: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)

Figure 25. PET: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)

Figure 26. Others: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)

Figure 27. Molecular Testing: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28. Lumbar Puncture: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29. Electroencephalography (EEG): Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)

Figure 30. Platform and Services: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)

Figure 31. Sample Slide: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)

Figure 32. Autosampler Unit: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)

Figure 33. Solutions and Platform: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)

Figure 34. Services: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)

Figure 35. Cerebral arteriogram: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)

Figure 36. Neurological and hearing tests/Neurocognitive Assessments: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)

Figure 37. Others: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)

Figure 38. Global Brain Cancer Diagnostic Market Share by Cancer Type - 2021 & 2028 (%)

Figure 39. Glioblastoma Multiforme: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)

Figure 40. Astrocytomas: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)

Figure 41. Ependymomas: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)

Figure 42. Meningiomas: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)

Figure 43. Low-Grade Tumors: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)

Figure 44. Oligodendroglioma: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)

Figure 45. Acoustic Neuroma: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)

Figure 46. Craniopharyngiomas: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)

Figure 47. Ganglioneuromas: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)

Figure 48. Others: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)

Figure 49. Global Brain Cancer Diagnostic Market Share by Tumor Size - 2021 & 2028 (%)

Figure 50. 0.2 cm3 to 100 cm3: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)

Figure 51. cm3 to 200 cm3: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)

Figure 52. Above 200 cm3: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)

Figure 53. Global Brain Cancer Diagnostic Market Share by End User- 2021 & 2028 (%)

Figure 54. Hospitals: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)

Figure 55. Specialty Clinics: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)

Figure 56. Diagnostic Centers and Research Institutes: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)

Figure 57. Ambulatory Surgical Centers: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)

Figure 58. Others: Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 (US$ Million)

Figure 59. North America: Brain Cancer Diagnostics Market, by Key Country – Revenue (2022) (US$ Million)

Figure 60. North America Brain Cancer Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 61. North America: Brain Cancer Diagnostics Market, by Country, 2022 & 2028 (%)

Figure 62. US: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 63. Canada: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 64. Mexico: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 65. Europe: Brain Cancer Diagnostics Market Revenue Overview, by Country, 2022(US$ MN)

Figure 66. Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 67. Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Country (%)

Figure 68. UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 69. Germany Brain Cancer Diagnostics Products Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 70. France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 71. Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 72. Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 73. Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 74. Asia Pacific Brain Cancer Diagnostic Market Overview, by Country (2021)

Figure 75. Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)

Figure 76. Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Country (%)

Figure 77. Japan: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)

Figure 78. China: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)

Figure 79. India: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)

Figure 80. South Korea: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)

Figure 81. Australia: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)

Figure 82. Rest of Asia Pacific: Brain Cancer Diagnostic Market – Revenue and Forecast to 2028 (US$ Million)

Figure 83. Middle East and Africa: Brain Cancer Diagnostics Market, by Key Country – Revenue (2022) (US$ ‘Million)

Figure 84. Middle East and Africa: Brain Cancer Diagnostics Market Revenue and Forecast to 2028 (US$ ‘Million)

Figure 85. Middle East and Africa: Brain Cancer Diagnostics Market, by Country, 2022 & 2028 (%)

Figure 86. UAE: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 87. Saudi Arabia: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 88. South Africa: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 89. Rest of Middle East and Africa: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 90. South and Central America: Brain Cancer Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)

Figure 91. South and Central America Brain Cancer Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 92. South and Central America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 93. Brazil: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 94. Argentina: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 95. Rest of South and Central America: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 96. Impact of COVID-19 Pandemic in North American Country Markets

Figure 97. Impact of COVID-19 Pandemic on Brain Cancer Diagnostics Market in Asia Pacific Countries

Figure 98. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 99. Impact Of COVID-19 Pandemic in Middle East & Africa Country Markets

Figure 100. Growth Strategies Done by the Companies in the Market, (%)

List of Companies:

1. THERMO FISHER SCIENTIFIC INC

2. Siemens Healthineers AG

3. GE Healthcare

4. MDxHealth

5. NantOmics

6. Biocept, Inc.

7. Koninklijke Philips N.V.

8. Canon Medical Systems

9. Hitachi, Ltd

10. Neusoft Medical Systems

11. KITZ HEIDELBERG

12. GENPATH

13. NVIDIA CORPORATION

14. ONCORA MEDICAL

15. BIOMIND

16. SOPHIA AND ONCODNA

17. Clinspec Diagnostics

18. Raindance Technologies, Inc

19. ROCHE DIAGNOSTICS

20. Illumina, Inc.

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the brain cancer diagnostic market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the global brain cancer diagnostic market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the brain cancer diagnostic market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

TOP